Aehr director granted 1,895 restricted shares

POSEDEL RHEA J reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

POSEDEL RHEA J reported acquisition or exercise transactions in this Form 4 filing.

Aehr Test Systems director Rhea J. Posedel reported a new equity grant of 1,895 shares of common stock. The grant was received at no cash cost and increases her directly held shares to 47,156.

The award is in the form of restricted stock units. According to the filing, one-fourth of the total RSU amount vests at the end of each three full calendar months following the grant date, as long as she continues to serve on the Board of Directors. The report also shows 396,375 shares of common stock held indirectly through a trust, which includes shares subject to unvested restricted stock units.

Insider Trade Summary

Grant/Award: 1,895 shares

Grant/Award 2 txns

Insider POSEDEL RHEA J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,895	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 47,156 shares (Direct); Common Stock — 396,375 shares (Indirect, By Trust)

Footnotes (2)

1. F1. One-fourth (1/4) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates.
2. F2. The amount reported includes shares subject to unvested restricted stock units.

Key Figures

RSU grant size: 1,895 shares Direct holdings after grant: 47,156 shares Indirect trust holdings: 396,375 shares +1 more

4 metrics

RSU grant size 1,895 shares Common stock grant with code A at $0.00 per share

Direct holdings after grant 47,156 shares Total directly owned common shares following the transaction

Indirect trust holdings 396,375 shares Common stock held indirectly by trust, including unvested RSUs

Grant price per share $0.00 per share Reported price for the 1,895-share equity award

Key Terms

restricted stock unit, unvested restricted stock units, By Trust, Board of Director

4 terms

restricted stock unit financial

"shares subject to the restricted stock unit awards shall vest at the end"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

unvested restricted stock units financial

"The amount reported includes shares subject to unvested restricted stock units."

By Trust financial

"total_shares_following_transaction": "396375.0000" ... "nature_of_ownership": "By Trust""

Board of Director financial

"provided that such recipient still serves as a member of the Board of Director"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AEHR director Rhea J. Posedel report on this Form 4?

Rhea J. Posedel reported receiving 1,895 shares of Aehr Test Systems common stock as a grant. The award was recorded at a price of $0.00 per share, indicating a compensation-related restricted stock unit grant rather than an open-market purchase.

How many AEHR shares does Rhea J. Posedel hold directly after this grant?

After the reported grant, Rhea J. Posedel directly holds 47,156 shares of Aehr Test Systems common stock. This figure comes from the post-transaction holdings column in the Form 4 for the non-derivative, directly owned shares.

How many AEHR shares does Rhea J. Posedel hold indirectly through a trust?

The Form 4 shows 396,375 shares of Aehr Test Systems common stock held indirectly by Rhea J. Posedel through a trust. This indirect position includes shares that are subject to unvested restricted stock units, according to a footnote in the filing.

How do the AEHR restricted stock units granted to Rhea J. Posedel vest?

The restricted stock unit award vests in four equal installments. One-fourth of the total RSU shares vests at the end of each three full calendar months following the grant date, provided she continues to serve on Aehr’s Board of Directors on each vesting date.

Was the AEHR stock grant to Rhea J. Posedel an open-market purchase?

No, the 1,895 AEHR shares were recorded at a price of $0.00 per share, indicating a grant or award. The transaction code is “A,” described as a grant, award, or other acquisition, rather than an open-market buy or sell transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2026 - 05:18 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

POSEDEL RHEA J

(Last) (First) (Middle)

C/O AEHR TEST SYSTEMS

400 KATO TERRACE

(Street)

FREMONT CALIFORNIA 94539

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AEHR TEST SYSTEMS [ AEHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)
	Director

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		A		1,895(1)	A	$0	47,156(2)	D
Common Stock								396,375	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. One-fourth (1/4) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates.

2. The amount reported includes shares subject to unvested restricted stock units.

Remarks:

	/s/Chris Siu, Attorney-in-Fact	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)